NCT04152408View on ClinicalTrials.gov

Clinical and Home Use Feasibility Study of a Percutaneous Optical Glucose Fiber Sensor

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Diabetes (DM)
Interventions
DEVICE

FiberSense System

FiberSense system, a novel CGM system, based on a fiber-optical sensor placed through the dermis of the patient.

Trial Locations (1)

69115

Diabetes Institut Heidelberg, Heidelberg

All Listed Sponsors
lead

EyeSense GmbH

INDUSTRY

NCT04152408 - Clinical and Home Use Feasibility Study of a Percutaneous Optical Glucose Fiber Sensor | Biotech Hunter | Biotech Hunter